USANA Health Sciences, Inc.
USNA
$19.41
-$0.50-2.51%
NYSE
| 04/04/2026 | 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Revenue | 250.22M | 226.20M | 213.67M | 235.85M | 249.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 250.22M | 226.20M | 213.67M | 235.85M | 249.54M |
| Cost of Revenue | 59.44M | 49.41M | 48.82M | 50.18M | 52.45M |
| Gross Profit | 190.78M | 176.79M | 164.86M | 185.66M | 197.09M |
| SG&A Expenses | 176.91M | 159.54M | 163.63M | 168.95M | 181.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 236.34M | 208.95M | 212.45M | 219.13M | 233.87M |
| Operating Income | 13.87M | 17.25M | 1.22M | 16.72M | 15.67M |
| Income Before Tax | 15.47M | 4.18M | 1.79M | 18.82M | 16.74M |
| Income Tax Expenses | 8.51M | 5.77M | 8.46M | 8.37M | 7.45M |
| Earnings from Continuing Operations | 6.96M | -1.60M | -6.66M | 10.44M | 9.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 556.00K | -180.00K | 140.00K | -789.00K | 112.00K |
| Net Income | 7.52M | -1.78M | -6.52M | 9.66M | 9.40M |
| EBIT | 13.87M | 17.25M | 1.22M | 16.72M | 15.67M |
| EBITDA | 22.15M | 25.81M | 9.14M | 24.46M | 24.01M |
| EPS Basic | 0.41 | -0.10 | -0.36 | 0.52 | 0.49 |
| Normalized Basic EPS | 0.56 | 0.59 | 0.07 | 0.59 | 0.56 |
| EPS Diluted | 0.41 | -0.10 | -0.36 | 0.52 | 0.49 |
| Normalized Diluted EPS | 0.56 | 0.59 | 0.07 | 0.59 | 0.55 |
| Average Basic Shares Outstanding | 18.40M | 18.30M | 18.29M | 18.51M | 19.05M |
| Average Diluted Shares Outstanding | 18.41M | 18.30M | 18.29M | 18.54M | 19.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |